[go: up one dir, main page]

EP0602178A4 - T cell receptor-based therapy for rheumatoid arthritis. - Google Patents

T cell receptor-based therapy for rheumatoid arthritis.

Info

Publication number
EP0602178A4
EP0602178A4 EP92919946A EP92919946A EP0602178A4 EP 0602178 A4 EP0602178 A4 EP 0602178A4 EP 92919946 A EP92919946 A EP 92919946A EP 92919946 A EP92919946 A EP 92919946A EP 0602178 A4 EP0602178 A4 EP 0602178A4
Authority
EP
European Patent Office
Prior art keywords
rheumatoid arthritis
cell receptor
based therapy
therapy
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92919946A
Other languages
English (en)
Other versions
EP0602178A1 (fr
Inventor
William V Williams
David B Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Wistar Institute of Anatomy and Biology
Original Assignee
University of Pennsylvania Penn
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn, Wistar Institute of Anatomy and Biology filed Critical University of Pennsylvania Penn
Publication of EP0602178A1 publication Critical patent/EP0602178A1/fr
Publication of EP0602178A4 publication Critical patent/EP0602178A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP92919946A 1991-08-28 1992-08-27 T cell receptor-based therapy for rheumatoid arthritis. Withdrawn EP0602178A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US75091391A 1991-08-28 1991-08-28
US750913 1991-08-28
US81791292A 1992-01-06 1992-01-06
US817912 1992-01-06
PCT/US1992/007289 WO1993004695A1 (fr) 1991-08-28 1992-08-27 Therapie de la polyarthrite rhumatoide basee sur le recepteur de lymphocytes t

Publications (2)

Publication Number Publication Date
EP0602178A1 EP0602178A1 (fr) 1994-06-22
EP0602178A4 true EP0602178A4 (en) 1995-10-25

Family

ID=27115338

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92919946A Withdrawn EP0602178A4 (en) 1991-08-28 1992-08-27 T cell receptor-based therapy for rheumatoid arthritis.

Country Status (4)

Country Link
EP (1) EP0602178A4 (fr)
JP (1) JPH07504399A (fr)
CA (1) CA2116526A1 (fr)
WO (1) WO1993004695A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9308581D0 (en) * 1993-04-26 1993-06-09 Univ Manitoba A method for induction of antigen-specific suppression of immune-response
EP0753060A4 (fr) * 1994-04-18 1999-11-24 New York Society Sequences receptrices de lymphocytes t conservees
GB9710820D0 (en) * 1997-05-27 1997-07-23 Univ Dundee Immunological method
CA2530184C (fr) 2003-06-27 2015-10-06 Haruo Sugiyama Methode de selection des patients candidats au vaccin wt1
AU2013206501B2 (en) * 2007-03-05 2016-05-19 International Institute Of Cancer Immunology, Inc. Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene and use of them
WO2008108257A1 (fr) 2007-03-05 2008-09-12 International Institute Of Cancer Immunology, Inc. Gène du récepteur des lymphocytes t spécifique d'un antigène de cancer, peptide codé par le gène et leur utilisation
GB0707208D0 (en) * 2007-04-13 2007-05-23 Istituto Superiore Di Sanito Novel disease treatments
US9803246B2 (en) 2011-06-28 2017-10-31 International Institute Of Cancer Immunology, Inc. Receptor gene for peptide cancer antigen-specific T cell

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340109A2 (fr) * 1988-04-28 1989-11-02 The Board Of Trustees Of The Leland Stanford Junior University Anti- Déterminants du récepteur de la céllule T pour le traitement des maladies autoimmunes
WO1991001133A1 (fr) * 1989-07-19 1991-02-07 Arthur Allen Vandenbark Peptides recepteurs de cellules t constituant une therapie contre des maladies autoimmunes et malignes
WO1991007508A1 (fr) * 1989-11-15 1991-05-30 National Jewish Center For Immunology And Respiratory Medicine Methode de mesure d'antigenes de surface de cellules en t chez les humains

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
ES2062519T5 (es) * 1989-03-21 2003-07-16 Immune Response Corp Inc Vacunacion y metodos contra enfermedades originadas a partir de respuestas patogenicas mediante poblaciones especificas de linfocitos t.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340109A2 (fr) * 1988-04-28 1989-11-02 The Board Of Trustees Of The Leland Stanford Junior University Anti- Déterminants du récepteur de la céllule T pour le traitement des maladies autoimmunes
WO1991001133A1 (fr) * 1989-07-19 1991-02-07 Arthur Allen Vandenbark Peptides recepteurs de cellules t constituant une therapie contre des maladies autoimmunes et malignes
WO1991007508A1 (fr) * 1989-11-15 1991-05-30 National Jewish Center For Immunology And Respiratory Medicine Methode de mesure d'antigenes de surface de cellules en t chez les humains

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9304695A1 *

Also Published As

Publication number Publication date
EP0602178A1 (fr) 1994-06-22
CA2116526A1 (fr) 1993-03-18
WO1993004695A1 (fr) 1993-03-18
JPH07504399A (ja) 1995-05-18

Similar Documents

Publication Publication Date Title
GB2255928B (en) Double lid system
EP0649569A4 (fr) Cellule electrochimique.
PH30886A (en) Containerization system.
SG43686A1 (en) Collaborative computer based system
EP0616199A3 (fr) Boîte dynamométrique et dispositif de pesage l'utilisant.
EP0646925A3 (fr) Appareil de mémoire pouvant entièrement s'aggrandir.
ZA927752B (en) Electrochemical cell.
EP0346478A4 (fr) Regulateur de commutation.
EP0602178A4 (en) T cell receptor-based therapy for rheumatoid arthritis.
KR920003523B1 (en) Tracking control apparatus
EP0627731A3 (fr) Appareil de reproduction comprenant des moyens de suivi de pistes.
DE58904130D1 (en) Elektrophotographischer toner.
AU8131694A (en) Treatment for rheumatoid arthritis
EP0223159A3 (en) Apparatus for determining the northerly direction
EP0632462A3 (fr) Cellule DRAM.
EP0608032A3 (en) Feeding device.
GR3027606T3 (en) Radar apparatus.
GB8824605D0 (en) Tap
GB8717755D0 (en) Treating rheumatoid arthritis
GB9310177D0 (en) Cell specific necrosis
DE58903960D1 (en) Elektrophotographische toner.
EP0378621A4 (en) Diagnostics and therapy for rheumatoid arthritis
GB2284990B (en) I.U.D. detector
OA09712A (en) Serum calcium lowering factor.
GB8819719D0 (en) Scanning systems

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940317

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT CH DE FR GB IT LI

A4 Supplementary search report drawn up and despatched

Effective date: 19950912

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT CH DE FR GB IT LI

17Q First examination report despatched

Effective date: 19960923

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980301